Beilstein J. Org. Chem. 2020, 16, 1936–1946.
2. Purser, S.; Moore, P. R.; Swallow, S.; Gouverneur, V. Chem. Soc. Rev.
phosphonate 29 or azide 28 is underway and will be reported in
due course.
3. Gillis, E. P.; Eastman, K. J.; Hill, M. D.; Donnelly, D. J.; Meanwell, N. A.
J. Med. Chem. 2015, 58, 8315–8359.
Conclusion
The selective synthesis of tetrasubstituted E- or Z-fluoroalkenes
was achieved by ring-opening reactions of fluoroalkylidene-
oxetanes, with the presence of the fluorine atom governing
regioisomeric attack of the bromide ion. Functionalization of
the resultant bromoalcohols with nucleophiles led, in two steps
from oxetanes, to a series of highly functionalized tetra-
substituted fluoroalkenes with excellent geometric control. This
method offers ready access to novel fluoroalkenes as potential
precursors of important drug mimics.
4. O’Hagan, D. J. Fluorine Chem. 2010, 131, 1071–1081.
5. Len, C.; Mackenzie, G. Tetrahedron 2006, 62, 9085–9107.
6. Bassetto, M.; Slusarczyk, M. Pharm. Pat. Anal. 2018, 7, 277–299.
7. Xie, M.-S.; Niu, H.-Y.; Qu, G.-R.; Guo, H.-M. Tetrahedron Lett. 2014,
8. De Clercq, E. Med. Res. Rev. 2013, 33, 1278–1303.
9. Schramm, V. L. Chem. Rev. 2018, 118, 11194–11258.
10.Kasthuri, M.; El Amri, C.; Lefort, V.; Périgaud, C.; Peyrottes, S.
11.Topalis, D.; Pradère, U.; Roy, V.; Caillat, C.; Azzouzi, A.; Broggi, J.;
Snoeck, R.; Andrei, G.; Lin, J.; Eriksson, S.; Alexandre, J. A. C.;
El-Amri, C.; Deville-Bonne, D.; Meyer, P.; Balzarini, J.; Agrofoglio, L. A.
12.Amblard, F.; Nolan, S. P.; Schinazi, R. F.; Agrofoglio, L. A. Tetrahedron
13.Varada, M.; Erande, N. D.; Kumar, V. A. RSC Adv. 2015, 5,
Supporting Information
The experimental section describing the preparation of all
new compounds, the copies of the NMR data (1H NMR,
13C NMR, 19F NMR), HOESY and NOESY experiments
and crystallographic data for compounds 1d, 4d and 25.
The CIF files of 1d, 4d and 25.
Supporting Information File 1
14.Champagne, P. A.; Desroches, J.; Paquin, J.-F. Synthesis 2015, 47,
Experimental section and copies of spectra.
15.Choi, M.-H.; Lee, C.-K.; Jeong, L. S.; Chun, M. W.; Kim, H.-D.
Nucleosides, Nucleotides Nucleic Acids 2001, 20, 681–684.
Supporting Information File 2
Crystallographic data (cif) for compounds E-1d, E-4d, and
Z-25.
16.Choi, M.-H.; Kim, H.-D. Arch. Pharmacal Res. 1997, 20, 501–506.
17.Prunier, A.; Calata, C.; Legros, J.; Maddaluno, J.; Pfund, E.;
Lequeux, T. J. Org. Chem. 2013, 78, 8083–8097.
18.Drouin, M.; Hamel, J.-D.; Paquin, J.-F. Synthesis 2018, 50, 881–955.
19.Landelle, G.; Bergeron, M.; Turcotte-Savard, M.-O.; Paquin, J.-F.
20.Yanai, H.; Taguchi, T. Eur. J. Org. Chem. 2011, 5939–5954.
Funding
This work was supported by the excellence laboratory LabEx
SYNORG (ANR-11-LABX-0029), ANR funding DALATAR
(ANR-19-CE18-0008-03) the Conseil Régional de Normandie
and the European FEDER funding.
21.Pfund, E.; Lequeux, T.; Gueyrard, D. Synthesis 2015, 47, 1534–1546.
22.Laporte, R.; Prunier, A.; Pfund, E.; Roy, V.; Agrofoglio, L. A.;
Lequeux, T. Eur. J. Org. Chem. 2015, 3121–3128.
ORCID® iDs
23.Yadav, J. S.; Singh, V. K.; Srihari, P. Org. Lett. 2014, 16, 836–839.
24.Burkhard, J. A.; Wuitschik, G.; Rogers-Evans, M.; Müller, K.;
Carreira, E. M. Angew. Chem., Int. Ed. 2010, 49, 9052–9067.
25.Wang, Z.; Chen, Z.; Sun, J. Angew. Chem., Int. Ed. 2013, 52,
26.Burkhard, J.; Carreira, E. M. Org. Lett. 2008, 10, 3525–3526.
References
1. Zhou, Y.; Wang, J.; Gu, Z.; Wang, S.; Zhu, W.; Aceña, J. L.;
Soloshonok, V. A.; Izawa, K.; Liu, H. Chem. Rev. 2016, 116, 422–518.
27.Jaśkowska, J.; Kowalski, P. J. Heterocycl. Chem. 2008, 45,
1945